Vanguard Group Inc Eloxx Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.15 - $7.2 $17,652 - $847,296	-117,680 Reduced 4.17%	2,704,513 $459,000
Q1 2022 May 13, 2022	SELL	$0.4 - $0.72 $86,118 - $155,013	-215,296 Reduced 7.09%	2,822,193 $1.58 Million
Q4 2021 Feb 14, 2022	SELL	$0.62 - $1.61 $5,920 - $15,373	-9,549 Reduced 0.31%	3,037,489 $2.14 Million
Q3 2021 Nov 12, 2021	SELL	$1.22 - $2.0 $10,344 - $16,958	-8,479 Reduced 0.28%	3,047,038 $4.97 Million
Q2 2021 Aug 13, 2021	BUY	$1.35 - $3.36 $4.12 Million - $10.3 Million	3,055,517 New	3,055,517 $6.08 Million

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.